Covered recipient · General Payments record
SUUR BILICILER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neuromuscular Medicine
General Payments · PY2018–2024
$6,257.67
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,517.50 | 3 |
| Food and Beverage | $801.38 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $2,343.51 | 6 |
| ARGENX US, INC. | $1,643.66 | 9 |
| Janssen Research & Development, LLC | $128.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.46 | 2 |
| HOSPIRA, INC. | $41.14 | 2 |
| Sarepta Therapeutics, Inc. | $35.67 | 1 |
| CSL Behring | $24.60 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.65 | 1 |
| GENZYME CORPORATION | $18.02 | 1 |
| ABBVIE INC. | $16.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.98 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103327428 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.65 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093902737 | CMS |
| ARGENX US, INC. | $1,437.50 | 01/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142113389 | CMS |
| ARGENX US, INC. | $26.38 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127173 | CMS |
| ARGENX US, INC. | $30.09 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127493 | CMS |
| ARGENX US, INC. | $32.46 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127607 | CMS |
| ARGENX US, INC. | $16.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127922 | CMS |
| ARGENX US, INC. | $23.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142121481 | CMS |
| ARGENX US, INC. | $27.41 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142128054 | CMS |
| ARGENX US, INC. | $38.02 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127876 | CMS |
| ARGENX US, INC. | $11.52 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142128052 | CMS |
| CSL Behring | $24.60 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134598935 | CMS |
| GENZYME CORPORATION | $18.02 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139752827 | CMS |
| HOSPIRA, INC. | $21.82 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131345942 | CMS |
| HOSPIRA, INC. | $19.32 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131438313 | CMS |
| Janssen Research & Development, LLC | $128.19 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077589121 | CMS |
| Sarepta Therapeutics, Inc. | $35.67 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126540671 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.68 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137489252 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.78 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137489256 | CMS |
| UCB, Inc. | $20.43 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459377 | CMS |
| UCB, Inc. | $35.00 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459381 | CMS |
| UCB, Inc. | $83.09 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459385 | CMS |
| UCB, Inc. | $1,040.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143459390 | CMS |
| UCB, Inc. | $1,040.00 | 11/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143459394 | CMS |
| UCB, Inc. | $124.99 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.